Browsing: Clinical

48-2 Caustic Ingestion.jpeg
Caustic ingestions cause either coagulative (acidic substance) or liquefactive (alkaline substance) necrosis. Management and treatment include observation, labs, imaging, endoscopy, and may require mo
48-2 COVID Airway.png
There are many perspectives available and early data to guide management of COVID-19 patients who present with respiratory failure. This article will review practice-altering data and the approach use
48-2 Global EM GEMSLP.png
The Global Emergency Medicine Student Leadership Program (GEMS LP), formerly known as the International Ambassador Mentorship Program (AMP), was established in 2018 as a joint effort of EMRA and the A
48-2 HOCM - Figure 2.png
Hypertrophic obstructive cardiomyopathy is the leading cause of non-traumatic sudden death in young individuals and most well-known for causing sudden cardiac death in athletes. While most known for b
48-2 Blunt Cardiac Injury.jpg
The ED diagnosis of blunt cardiac injury is difficult, as trauma patients often have various concomitant injuries that may serve as distractors.
48-2 NSAID risk.jpg
NSAIDs are the most commonly used class of drugs in the world. They possess analgesic, antipyretic, and anti-inflammatory properties. Its GI side effects are most apparent and well-documented and can
48-2 Septic Shoulder.jpeg
While Methicillin-resistant Staphylococcus aureus (MRSA) is a well-known and feared cause of septic arthritis, P. aeruginosa needs to be considered by the emergency physician when caring for an IV dru
48-2 President Message.jpg
As the COVID-19 pandemic evolves in 2021, major EM groups have once again stepped up to provide a unified roadmap to the away rotation and eSLOE process. Class of 2022, your training may look differe
48-2 TEE.jpg
Cardiac arrest is one of the most demanding presentations for emergency physicians to manage. Focused transesophageal echocardiography (TEE) has emerged as a valuable aid.
48-2 Hemopericardium - cxr-supine-ap Fig 1.jpg
Direct oral anticoagulants (DOACs) have become the preferred anticoagulant medication for patients with nonvalvular atrial fibrillation, deep vein thrombosis, and pulmonary embolism. However, recent c